Read + Share
Stanbouly D, Philipone E, Morlandt AB, Kaleem A, et al. Adverse events secondary to cetuximab therapy in head & neck cancer therapy and
risk factors for serious outcomes. Oral Oncol 2022;131:105952.
PMID: 35717723
|
 |
|
Stanbouly D, Philipone E, Morlandt AB, Kaleem A, et al. Adverse events secondary to cetuximab therapy in head & neck cancer therapy and
risk factors for serious outcomes. Oral Oncol 2022;131:105952.
PMID: 35717723
|
|
|
|